Development of Novel Inhibitors Targeting Intracellular Steps of Peptidoglycan Biosynthesis

E-ISSN： 1873-4286|13|22|2283-2309

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.22, 2007-08, pp. : 2283-2309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR-γ inhibitors as novel tubulin-targeting agents

By Schaefer Katherine L

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 923-926

Informa Healthcare

Access to resources Recommend Favorite

Advances in the development of novel aggrecanase inhibitors

By Gilbert Adam M Bikker Jack A O'Neil Steven V

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Novel inhibitors in development for hepatocellular carcinoma

By Wörns Marcus Alexander Galle Peter Robert

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 615-629

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors and Prodrugs Targeting CYP1: A Novel Approach in Cancer Prevention and Therapy

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 519-552

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Inhibitors of AKT: Assessment of a Different Approach Targeting the Pleckstrin Homology Domain

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2727-2742

Bentham Science Publishers

Access to resources Recommend Favorite